Fengyuan Pharmaceutical: Announcement of Resolutions of the 17th 9th Board of Supervisors
Fengyuan Pharmaceutical: Announcement of the 9th 19th Board of Directors Resolutions
Anhui Fengyuan Pharmaceutical: Shareholders' Meeting Rules of Procedure (Revised in May 2024)
Anhui Fengyuan Pharmaceutical: 000153 Fengyuan Pharmaceutical Investor Relations Management Information 20240517
Anhui Fengyuan Pharmaceutical: Announcement on holding the 2023 Annual Results Briefing
Anhui Fengyuan Pharmaceutical: Notice on obtaining a drug registration certificate
Anhui Fengyuan Pharmaceutical: Independent Director's 2023 Debriefing Report (Wu Cisheng)
Anhui Fengyuan Pharmaceutical: Fengyuan Pharmaceutical Independent Director Work System
Anhui Fengyuan Pharmaceutical: Internal Control Audit Report
Anhui Fengyuan Pharmaceutical: Independent Director's 2023 Debriefing Report (Chen Jiemiao)
Anhui Fengyuan Pharmaceutical: Announcement on the renewal of the 2024 Audit Institution
Anhui Fengyuan Pharmaceutical: 2023 Annual Audit Report
Anhui Fengyuan Pharmaceutical: Announcement of Supervisory Board Resolutions
Anhui Fengyuan Pharmaceutical: Announcement of Board Resolutions
Anhui Fengyuan Pharmaceutical: Report on the work of the company's 2023 board of supervisors
Anhui Fengyuan Pharmaceutical: Independent Director's 2023 Debriefing Report (Zhu Weidong)
Anhui Fengyuan Pharmaceutical: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Anhui Fengyuan Pharmaceutical: Announcement on the forecast for daily related transactions in 2024
Anhui Fengyuan Pharmaceutical: Annual special audit report on the expenditure of related parties' funds
Fengyuan Pharmaceutical: Progress Notice on Providing Guarantees for Subsidiaries